Review
doi: 10.1016/j.clon.2003.10.009.
Positron emission tomography imaging of cell proliferation in oncology
Affiliations
- PMID: 15191004
- DOI: 10.1016/j.clon.2003.10.009
Item in Clipboard
Review
Positron emission tomography imaging of cell proliferation in oncology
Clin Oncol (R Coll Radiol).
2004 May.
Abstract
Tumour-cell proliferation is a hallmark of the malignant phenotype. Positron emission tomography (PET) offers a unique method of imaging biological and biochemical changes in vivo. Radiolabelled thymidine and thymidine analogues are currently in development as PET tracers. By studying the uptake and kinetics of such compounds using PET, a measure of DNA synthesis and hence cell proliferation can be obtained. Molecular imaging of cellular proliferation with PET is now possible, and has the potential to play an important role in the evaluation of efficacy of new anti-cancer agents.
Similar articles
-
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.Nucl Med Commun. 2009 Dec;30(12):908-17. doi: 10.1097/MNM.0b013e32832ee93b. Nucl Med Commun. 2009. PMID: 19794320 Review.
-
Pharmacodynamics of radiolabelled anticancer drugs for positron emission tomography.Curr Pharm Des. 2003;9(11):931-44. doi: 10.2174/1381612033455251. Curr Pharm Des. 2003. PMID: 12678876 Review.
-
PET imaging of cellular proliferation.Radiol Clin North Am. 2005 Jan;43(1):153-67. doi: 10.1016/j.rcl.2004.09.005. Radiol Clin North Am. 2005. PMID: 15693654 Review.
-
PET imaging of tumor growth: not as easy as it looks.Clin Cancer Res. 2012 Mar 1;18(5):1189-91. doi: 10.1158/1078-0432.CCR-11-3198. Epub 2012 Jan 24. Clin Cancer Res. 2012. PMID: 22275505 Free PMC article.
-
Measuring tumor pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidine.Biochim Biophys Acta. 2004 Dec 17;1705(2):91-102. doi: 10.1016/j.bbcan.2004.09.007. Biochim Biophys Acta. 2004. PMID: 15588764 Review.
Cited by
-
The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.Cancer Metastasis Rev. 2008 Dec;27(4):575-87. doi: 10.1007/s10555-008-9148-5. Cancer Metastasis Rev. 2008. PMID: 18512023 Free PMC article. Review.
-
Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone.Mol Imaging Biol. 2009 Sep-Oct;11(5):308-21. doi: 10.1007/s11307-009-0216-1. Epub 2009 May 22. Mol Imaging Biol. 2009. PMID: 19462209
-
Disseminated Skeletal Muscle and Cardiac Metastasis from Squamous Cell Carcinoma of the Lung Detected with FDG and FLT PET/CT.World J Nucl Med. 2016 Sep;15(3):215-7. doi: 10.4103/1450-1147.167607. World J Nucl Med. 2016. PMID: 27651747 Free PMC article.
-
Elevation of radiolabelled thymidine uptake in RIF-1 fibrosarcoma and HT29 colon adenocarcinoma cells after treatment with thymidylate synthase inhibitors.Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):981-7. doi: 10.1007/s00259-005-0060-8. Epub 2006 Mar 28. Eur J Nucl Med Mol Imaging. 2006. PMID: 16568206
-
Preliminary 19F-MRS Study of Tumor Cell Proliferation with 3'-deoxy-3'-fluorothymidine and Its Metabolite (FLT-MP).Contrast Media Mol Imaging. 2017 Sep 26;2017:3981358. doi: 10.1155/2017/3981358. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29097919 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
